Recruiting studies
RSV vaccine
Study
Participate in our clinical study evaluating the efficacy of an investigational vaccine against respiratory syncytial virus (RSV).
The situation
Respiratory syncytial virus (RSV) is a common virus that affects the respiratory tract. Although it often resembles a mild cold, it can lead to more serious lung complications, such as bronchitis or pneumonia, particularly in older adults.
Even in people who feel in excellent health, aging naturally alters the immune system. Developing and refining innovative vaccines remains essential to provide safe, effective, and preventive protection against RSV and to preserve the health and independence of older adults.
Study objective
This clinical study aims to evaluate the efficacy, safety, and immune response of an investigational vaccine designed to prevent RSV infections.
This study is open to individuals aged 60 and older who are in good general health and wish to receive rigorous medical monitoring while contributing to the advancement of preventive medicine.
What participating in this study entails:
- Access to an innovative vaccine and medical monitoring: You will have access to the study vaccine and receive close medical monitoring throughout the protocol, at no cost to you.
- Specialized medical care: You will receive a comprehensive health assessment and regular study-related follow-ups, provided by a team of qualified healthcare professionals (doctors, nurses, and research staff).
- Compensation for your time and travel: Financial compensation is provided to cover the time spent on visits and your travel expenses related to the protocol.
- No hidden costs: All consultations, medical examinations, tests, and vaccines included in the protocol are fully covered.
Eligibility and Voluntary Participation
Participation in this research is entirely voluntary. You may withdraw from the study at any time, without providing a reason and without affecting the quality of your future care.
Each medical profile is rigorously reviewed by our team of professionals.
To be eligible, you must:
- Be 60 years of age or older.
- Be in good general health (or have stable medical conditions).
Would you like more information?
Our recruitment team is available to explain the study process, answer your questions, and verify your eligibility.
Please complete the eligibility form below.
I want to apply to this clinical study
Participate in the study of Québec Participate in the study of Victoriaville
For more information, contact us at
581 477-3439 (Québec), 819 260-1172 (Victoriaville)
or at 1-844-739-3439 (toll free), or fill the online form.
The study process in pictures
Explanation
Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.
Meeting
Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.
Decision
Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.
Tests
Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.
Departure
Step 5 | If you are eligible, you may then begin a clinical study with us.
